Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.4.2 was added to the history; the government funding lapse notice and the v3.4.1 revision entry were removed.SummaryDifference0.8%

- Check23 days agoChange DetectedThe page history shows a government funding notice being added and a revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check30 days agoChange DetectedUI enhancements to the history page include a Show glossary option, green highlights for additions, red highlights for deletions, and explanatory color-coding text; the revision label updates from v3.3.4 to v3.4.0.SummaryDifference1%

- Check44 days agoChange DetectedThe record history now shows a new revision entry: v3.3.4. The previous revision entry v3.3.3 has been removed from the list.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.3.3 is added to the record history; HHS Vulnerability Disclosure and Revision: v3.3.2 entries are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check94 days agoChange DetectedA new revision entry v3.3.2 was added to the record history, and the older v3.2.0 entry was removed.SummaryDifference0.1%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.